[The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
D000818:Animals; D001381:Azepines / Q000008:administration & dosage / Q000494:pharmacology*; D001565:Benzoates / Q000008:administration & dosage / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004077:Digoxin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D004285:Dogs; D004338:Drug Combinations; D006339:Heart Rate / Q000187:drug effects; D007275:Injections, Intravenous; D009200:Myocardial Contraction / Q000187:drug effects*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D001381:Azepines; D001565:Benzoates; D004338:Drug Combinations; D014665:Vasodilator Agents; D004077:Digoxin
Die Beeinflussung der myokardialen Kontraktilität durch intravenöse Gaben von Dilazep, beta-Acetyldigoxin und Dilazep/beta-Acetyldigoxin am Hund